Acta Chir Orthop Traumatol Cech. 2017; 84(3):208-210 | DOI: 10.55095/achot2017/031
Cementless Total Hip Arthroplasty in Primary Myelofibrosis - a Case ReportCase report
- 1 Klinik für Orthopädie, Friedrich-Schiller Universität Jena, Campus Eisenberg, Eisenberg, Germany
- 2 Klinik für Innere Medizin II, Abt. Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Germany
There is a great deal of data available, in part contradictory, on the best fixation technique to use for total hip arthroplasty (THA) in hip osteoarthritis. Both the cementless and the cemented versions offer excellent long-term outcomes - if the respective technique is applied correctly. However, as far as we know, no recommendation has been made regarding cemented vs. cementless THA in primary myelofibrosis.
The case described here concerns a very active 76-year-old patient with primary myelofibrosis. This is a rare hematological disease. It develops from clonal hematopoiesis with impaired blood formation and progressive bone marrow fibrosis. An MRI scan of the patients pelvis showed a marked spotted change over all of the imaged bone.
Ultimately, in preoperative planning we decided in favor of a proven cementless implant (Allofit Alloclassic cup and the CLS Spotorno stem from Zimmer). Complication-free osseous integration of the cementless implants was observed.
Histologic analysis of the bone showed a focally sclerotically altered bone structure. Neither osteoporosis nor osteopenia were found.
In our opinion, taking into account all other indication criteria, there is no reason not to perform a cementless THA implantation in the presence of primary myelofibrosis.
Keywords: hip, primary myelofibrosis, cementless, THA, total hip replacement
Published: June 1, 2017 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Australian Orthopaedic Association National Joint Replacement Registry. Annual Report. Adelaide:AOA; 2015.
- Bauer R, Kerschbaumer F, Poisel S, Oberthaler W. The transgluteal approach to the hip joint. Arch Orthop Trauma Surg. 1979;95:47-49.
Go to original source...
Go to PubMed...
- Mäkelä KT, Matilainen M, Pulkkinen P, Fenstad AM, Havelin L, Engesaeter L, Furnes O, Pedersen AB, Overgaard S, Kärrholm J, Malchau H, Garellick G, Ranstam J, Eskelinen A. Failure rate of cemented and uncemented total hip replacements: register study of combined Nordic database of four nations. BMJ. 2014;348:f7592.
Go to original source...
Go to PubMed...
- Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51:224-232.
Go to PubMed...
- Sendtner E, Boluki D, Grifka J. [Current state of doing minimal invasive total hip replacement in Germany, the use of new implants and navigation - results of a nation-wide survey]. Z Orthop Unfall. 2007;145:297-302.
Go to original source...
Go to PubMed...
- Streit MR, Innmann MM, Merle C, Bruckner T, Aldinger PR, Gotterbarm T. Long-term (20- to 25-year) results of an uncemented tapered titanium femoral component and factors affecting survivorship. Clin Orthop Relat Res. 2013;471:3262-3269.
Go to original source...
Go to PubMed...
- Streit MR, Weiss S, Andreas F, Bruckner T, Walker T, Kretzer JP, Ewerbeck V, Merle C. 10-year results of the uncemented Allofit press-fit cup in young patients. Acta Orthop. 2014;85:368-374.
Go to original source...
Go to PubMed...
- Swedish Hip Arthroplasty Register (SHAR). Annual Report 2013. www.shpr.se.
- Tefferi A. Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014;89:915-925.
Go to original source...
Go to PubMed...